CM/TNS/24/5719 - NHS National Framework for the supply of Pomalidomide
Who
| Buyer | NHS England — not a council we hold |
| Supplier | Amarox Limited |
| Supplier | Grindeks Kalceks UK Ltd |
| Supplier | Thornton and Ross Ltd |
| Supplier | Wockhardt UK Limited |
| Supplier | Zentiva Pharma UK Ltd |
What
Project title: NHS National Framework for the supply of Pomalidomide commencing 1 April 2025 Offer reference number: CM/TNS/24/5719 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5719/01 - Pomalidomide Lot 1 CESW: 01/04/2025 to 31/05/2026 Lot 2 LSNE: 01/04/2025 to 31/05/2026 Lot 3 NWLN: 01/04/2025 to 31/05/2026 Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Dates and source
| Runs | 1 Apr 2025 to 31 May 2026 |
| OCID | ocds-b5fd17-5e5a6698-0513-4adc-93db-01a73e5d703a |
| Notice | Read it on Contracts Finder |
Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.